Stammdaten
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Unternehmen & Branche
| Name | Silexion Therapeutics Corp |
|---|---|
| Ticker | SLXN |
| CIK | 0002022416 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | G1281K106 |
|---|---|
| ISIN | USG1281K1063 |
| Typ | Common Stock |
| Marktkapitalisierung | 352.622 USD |
| Beta | 0,06 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -11,912,000 | 8.96 | 7,215,000 | 2,603,000 | |
| 2025-09-30 | 10-Q | -3,262,000 | 2.88 | 11,614,000 | 6,977,000 | |
| 2025-06-30 | 10-Q | -2,503,000 | 4.32 | 5,797,000 | 120,000 | |
| 2025-03-31 | 10-Q | -1,735,000 | 0.26 | 8,308,000 | 2,586,000 | |
| 2024-12-31 | 10-K | -16,519,000 | 394.94 | 2,863,000 | -3,989,000 | |
| 2024-09-30 | 10-Q | -11,860,000 | 274.25 | 3,087,000 | -4,579,000 | |
| 2024-06-30 | 10-Q | -1,489,000 | 197.80 | 2,315,000 | -18,257,000 | |
| 2024-03-31 | 10-Q | -1,423,000 | 12.29 | 3,585,000 | ||
| 2023-12-31 | 10-K | -5,108,000 | 44.23 | 5,256,000 | -15,476,000 | |
| 2023-09-30 | 10-Q | -809,000 | 0.78 | |||
| 2023-06-30 | 10-Q | -1,876,000 | 6.54 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 12,205 | 0 | 12,205 | 23,434 | Neu | +100,0% | |
| Oasis Management Co Ltd. | 11,111 | 0 | 11,111 | 21,333 | Neu | +100,0% | |
| Polar Asset Management Partners Inc. | 743,475 | 0 | 743,475 | 19,330 | Neu | +100,0% | |
| ARISTEIA CAPITAL, L.L.C. | 236,546 | 0 | 236,546 | 6,292 | Neu | +100,0% | |
| MONTAG A & ASSOCIATES INC | 3,000 | 0 | 3,000 | 5,760 | Neu | +100,0% | |
| Clear Street Group Inc. | 218,965 | 0 | 218,965 | 5,693 | Neu | +100,0% | |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ | 150,000 | 0 | 150,000 | 4,080 | Neu | +100,0% | |
| UBS Group AG | 1,691 | 0 | 1,691 | 3,247 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 121,237 | 0 | 121,237 | 3,152 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 1,060 | 0 | 1,060 | 2,035 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 74,910 | 0 | 74,910 | 1,948 | Neu | +100,0% | |
| PICTON MAHONEY ASSET MANAGEMENT | 57,175 | 0 | 57,175 | 1,487 | Neu | +100,0% | |
| Context Capital Management, LLC | 51,183 | 0 | 51,183 | 1,331 | Neu | +100,0% | |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 50,000 | 0 | 50,000 | 1,300 | Neu | +100,0% | |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 38,150 | 0 | 38,150 | 992 | Neu | +100,0% | |
| Neuberger Berman Group LLC | 31,552 | 0 | 31,552 | 820 | Neu | +100,0% | |
| GABELLI FUNDS LLC | 30,496 | 0 | 30,496 | 793 | Neu | +100,0% | |
| Pflug Koory, LLC | 333 | 0 | 333 | 639 | Neu | +100,0% | |
| STIFEL FINANCIAL CORP | 16,000 | 0 | 16,000 | 416 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 12,500 | 0 | 12,500 | 325 | Neu | +100,0% | |
| Saba Capital Management, L.P. | 11,937 | 0 | 11,937 | 318 | Neu | +100,0% | |
| JONES FINANCIAL COMPANIES LLLP | 26 | 0 | 26 | 50 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 100 | 0 | 100 | 3 | Neu | +100,0% | |
| Kepos Capital LP | 100,000 | 0 | 100,000 | 3 | Neu | +100,0% | |
| Mint Tower Capital Management B.V. | 25,000 | 0 | 25,000 | 1 | Neu | +100,0% | |
| HRT FINANCIAL LP | 21,260 | 0 | 21,260 | 0 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | Shirvan Mitchell | Officer, CSO and CDO | Open Market Sale | -22,818 | 1.36 | -31,032.48 | -100,0% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| CITADEL ADVISORS LLC | 12,205 | 23,434 | 22.36 |
| Oasis Management Co Ltd. | 11,111 | 21,333 | 20.36 |
| Polar Asset Management Partners Inc. | 743,475 | 19,330 | 18.45 |
| ARISTEIA CAPITAL, L.L.C. | 236,546 | 6,292 | 6.00 |
| MONTAG A & ASSOCIATES INC | 3,000 | 5,760 | 5.50 |
| Clear Street Group Inc. | 218,965 | 5,693 | 5.43 |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ | 150,000 | 4,080 | 3.89 |
| UBS Group AG | 1,691 | 3,247 | 3.10 |
| GOLDMAN SACHS GROUP INC | 121,237 | 3,152 | 3.01 |
| SBI Securities Co., Ltd. | 1,060 | 2,035 | 1.94 |
| JANE STREET GROUP, LLC | 74,910 | 1,948 | 1.86 |
| PICTON MAHONEY ASSET MANAGEMENT | 57,175 | 1,487 | 1.42 |
| Context Capital Management, LLC | 51,183 | 1,331 | 1.27 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 50,000 | 1,300 | 1.24 |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 38,150 | 992 | 0.95 |
| Neuberger Berman Group LLC | 31,552 | 820 | 0.78 |
| GABELLI FUNDS LLC | 30,496 | 793 | 0.76 |
| Pflug Koory, LLC | 333 | 639 | 0.61 |
| STIFEL FINANCIAL CORP | 16,000 | 416 | 0.40 |
| MILLENNIUM MANAGEMENT LLC | 12,500 | 325 | 0.31 |